Warner Music Group Corp vs Health Care Select Sector SPDR Fund — how do they compare? Warner Music Group Corp trades at $28.16 (market cap $14.73B), while Health Care Select Sector SPDR Fund trades at $167.04. The key difference: Warner Music Group Corp pays a 2.84% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Warner Music Group Corp nearer its low. Which is the better fit depends on your goals.
| WMG | XLV | |
|---|---|---|
Market Cap | $14.73B | — |
Sector | Media | — |
52-Week High | $34.72 | $175.68 |
52-Week Low | $23.65 | $134.13 |
Enterprise Value | $19.03B | — |
Dividend Yield | 2.84% | — |
Signals from Pluang's Aura AI — not financial advice
Warner Music Group (WMG) trades at $28.03, down 2.61% on the day, with a bearish technical signal. Recent quarterly earnings show mixed results, with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue has grown steadily from $5.9B in 2022 to $6.7B in 2025, though net income margin declined to 5.44%. Analyst consensus is bullish with 16 buy ratings, and recent news highlights AI partnerships and licensing renewals.
Outlook is positive due to strong streaming growth and strategic AI initiatives, but risks include margin pressure and leadership changes. The stock offers value with a P/E of 22.42 and robust cash flow, though near-term volatility may persist amid market sentiment shifts.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Trailing returns across standard periods
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →